Phase II trial of docetaxel for cholangiocarcinoma.
Saved in:
| Title: | Phase II trial of docetaxel for cholangiocarcinoma. |
|---|---|
| Authors: | Pazdur R; University of Texas M.D. Anderson Cancer Center, Houston 77030, USA., Royce ME, Rodriguez GI, Rinaldi DA, Patt YZ, Hoff PM, Burris HA |
| Source: | American journal of clinical oncology [Am J Clin Oncol] 1999 Feb; Vol. 22 (1), pp. 78-81. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Print ISSN: 0277-3732 (Print) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
